联系方式：400-650-8506
CNEN
产品名称 Abiraterone - CB 7598
产品货号 Axon 1873 CAS [154229-19-3] MF C24H31NOMW 349.51 Purity: 100% Optical purity: Optically pure Moderately soluble in DMSO Description Inhibitor of the steroidal enzyme 17 α-hydroxylase/C17,20 lyase (CYP17A1); a drug used in castration-resistant prostate cancer (CRPC); active component of its formulated prodrug abiraterone acetate (Axon 1874), which is also available References Certificates Categories Extra info G Attard et al. Selective blockade of androgenic steroid synthesis by novel lyase inhibitors as a therapeutic strategy for treating metastatic prostate cancer. BJU Int. 2005, 96 (9), 1241–1246.    JE Ang et al. CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer. Br. J. Cancer 2009, 100(5), 671–675.  Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Diabetes & Metabolism Endocrinology EC 1.14.99.9 Cytochrome P450 Inhibitor of CYP17A1 Chemical name (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol Parent CAS No. [154229-19-3] Order Size Unit Price Stock 10 mg €90.00 In Stock
产品价格 现货询价，电话：010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情

Abiraterone - CB 7598

Based on 12 reference(s) in Google Scholar 9 10 12

Axon 1873

CAS [154229-19-3]

MF C24H31NO
MW 349.51

  • Purity: 100%
  • Optical purity: Optically pure
  • Moderately soluble in DMSO

Abiraterone

Description

Inhibitor of the steroidal enzyme 17 α-hydroxylase/C17,20 lyase (CYP17A1); a drug used in castration-resistant prostate cancer (CRPC); active component of its formulated prodrug abiraterone acetate (Axon 1874), which is also available
产品资料